All authors were contacted, but none provided additional data.
Only theCHARISMA study randomized peoplewithout evidence
of cardiovascular disease, but separate findings for these primary
patients were not presented and could not be obtained from the
trialists; consequently a comparison between efficacy of treatment
in primary versus secondary prevention cannot be made.